OBJECTIVE. The purpose of this article is to discuss the application of a new CT reconstruction algorithm, adaptive statistical iterative reconstruction (ASIR), to reduce radiation dose at body CT and to provide imaging examples in comparison with low-dose and standard-dose filtered back projection CT.CONCLUSION. The ASIR reconstruction algorithm is a promising technique for providing diagnostic quality CT images at significantly reduced radiation doses.

Dual-energy imaging is a promising new development in computed tomography (CT) that has the potential to improve lesion detection and characterization beyond levels currently achievable with conventional CT techniques. In dual-energy CT (DECT), the simultaneous use of two different energy settings allows the differentiation of materials on the basis of their energy-related attenuation characteristics (material density). The datasets obtained with DECT can be used to reconstruct virtual unenhanced images as well as iodinated contrast material-enhanced material density images, obviating the standard two-phase (unenhanced and contrast-enhanced) scanning protocol and thus helping minimize the radiation dose received by the patient. Single-source DECT, which is performed with rapid alternation between two energy levels, can also generate computed monochromatic images, which are less vulnerable to artifacts such as beam hardening and pseudoenhancement and provide a higher contrast-to-noise ratio than polychromatic images produced by conventional CT. Familiarity with the capabilities of DECT may help radiologists improve their diagnostic performance.

Major technologic advances in magnetic resonance (MR) imaging, including the advent of novel pulse sequences (eg, diffusion-weighted and steady-state free precession sequences) and the use of hepatocyte-specific contrast agents, have led to better image quality and shorter acquisition times, resulting in dramatic improvements in the noninvasive detection and characterization of hepatic lesions, particularly hypervascular neoplasms. However, as the role of MR imaging in clinical evaluation of the liver continues to evolve, keeping abreast of new developments can be daunting as well as confusing. A systematic approach that makes use of a simple decision algorithm can help differentiate hypervascular hepatic lesions on the basis of their distinguishing MR imaging characteristics and related clinical information.

Magnetic resonance (MR) cholangiopancreatography has proved a robust and noninvasive imaging modality for evaluating the biliary and pancreatic ducts without the use of ionizing radiation. Although MR cholangiopancreatography reliably depicts the main extrahepatic and intrahepatic bile ducts, it does not depict the segmental intrahepatic ducts unless they are dilated. The segmental ducts are difficult to visualize with MR cholangiopancreatography because of their small caliber and the limited spatial resolution and signal-to-noise ratio achievable with standard MR pulse sequences. However, visualization of the normal (ie, nondistended) biliary system is necessary for the evaluation of donor candidates for living related liver transplantation. Because of the prevalence of variant biliary anatomy, MR cholangiopancreatography is often used for preoperative evaluation of prospective liver donors. Intravenous morphine administered prior to MR cholangiopancreatography can improve image quality by causing the sphincter of Oddi to contract, which increases pressure in and distention of the biliary and pancreatic ducts. Morphine administration may also be particularly helpful for the evaluation of patients with primary sclerosing cholangitis, malignant neoplasms such as cholangiocarcinoma, or cystic and non-organ-deforming benign pancreatic neoplasms.